Skip to Main Content

INFORMATION FOR

Dinesh Pashankar, MD, MBA

Professor; Regional Director, Ambulatory Services, Yale Medicine; Medical Director, Yale Clinical Optimization Service; Director, Pediatric IBD program, Pediatrics

Contact Information

Dinesh Pashankar, MD, MBA

Office Location

Mailing Address

  • Pediatric Gastroenterology & Hepatology

    333 Cedar Street, PO Box 208064

    New Haven, CT 06520-8064

    United States

Research Summary

Dr. Pashankar focuses on inflammatory bowel disease (IBD) in children. He has published a number of clinical studies on obesity, constipation and IBD. Currently he is focusing on IBD in children.. He has worked with medical students on research projects and that has led to publications in reputed journals with students being co-authors.

Specialized Terms: Inflammatory bowel disease, Crohn's disease, ulcerative colitis

Coauthors

Research Interests

Gastroenterology; Obesity; Pediatrics; Inflammatory Bowel Diseases

Selected Publications

  • OP025 Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practiceSteiner S, King E, Park K, Pashankar D, Shashidhar H, Sudel B, Eichner S, Chen S, Pratt J, Colletti R. OP025 Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice Journal Of Crohn's And Colitis 2017, 11: s15-s16. DOI: 10.1093/ecco-jcc/jjx002.024.
  • P-220 To Assess the Rate of Adequate Immune Response to Primary Hepatitis B Vaccination Series in Patients with IBDPhatak U, Rojas-Velasquez D, Pashankar D. P-220 To Assess the Rate of Adequate Immune Response to Primary Hepatitis B Vaccination Series in Patients with IBD Inflammatory Bowel Diseases 2016, 22: s76. DOI: 10.1097/01.mib.0000480330.52952.bf.
  • Obesity and Gastrointestinal Disorders in ChildrenPhatak U, Phadke M, Pashankar D. Obesity and Gastrointestinal Disorders in Children 2016, 149-157. DOI: 10.1007/978-3-319-19821-7_12.
  • Su1775 Duodenitis in Children Undergoing Upper EndoscopyAlper A, Rojas-Velasquez D, Morotti R, Escalera S, Pashankar D, Hardee S. Su1775 Duodenitis in Children Undergoing Upper Endoscopy Gastrointestinal Endoscopy 2014, 79: ab399. DOI: 10.1016/j.gie.2014.02.519.
  • Novel Characterization of Biliary Pancreatitis in ChildrenMa M, Bai H, Park A, Latif S, Northrup V, Pashankar D, Barth B, Bhandari V, Husain S. Novel Characterization of Biliary Pancreatitis in Children Gastroenterology 2011, 140: s-383. DOI: 10.1016/s0016-5085(11)61568-0.
  • 314o: Two-Day Bowel Preparation With Polyethylene Glycol 3350 and Bisacodyl: A New Safe and Effective Regimen for Colonoscopy in ChildrenPhatak U, Johnson S, Husain S, Pashankar D. 314o: Two-Day Bowel Preparation With Polyethylene Glycol 3350 and Bisacodyl: A New Safe and Effective Regimen for Colonoscopy in Children Gastrointestinal Endoscopy 2010, 71: ab108. DOI: 10.1016/j.gie.2010.03.019.
  • T1124 Common Clinical Problems Facing Pediatric Gastroenterologists in Outpatient Clinics At Academic CentersPashankar D, Uc A, Saeed S, Smith L, Huang J, Treem W, Gilger M. T1124 Common Clinical Problems Facing Pediatric Gastroenterologists in Outpatient Clinics At Academic Centers Gastroenterology 2009, 136: a-504. DOI: 10.1016/s0016-5085(09)62323-4.
  • T1155 Constipation in Children Receiving Chemotherapy for Cancer: Prevalence, Risk Factors and Severity of the ProblemSeason H, Pashankar F, Beardsley D, McNamara J, Pashankar D. T1155 Constipation in Children Receiving Chemotherapy for Cancer: Prevalence, Risk Factors and Severity of the Problem Gastroenterology 2009, 136: a-511. DOI: 10.1016/s0016-5085(09)62354-4.
  • 957 Pediatric Pancreatitis: Epidemiology, Etiologies, and Recurrence, a Retrospective StudyLatif S, Park A, Shah A, Tian J, Hsiao A, Pashankar D, Bhandari V, Nagar A, Husain S. 957 Pediatric Pancreatitis: Epidemiology, Etiologies, and Recurrence, a Retrospective Study Gastroenterology 2008, 134: a-141. DOI: 10.1016/s0016-5085(08)60657-5.
  • PREVALENCE OF GASTROESOPHAGEAL REFLUX SYMPTOMS IN OBESE CHILDRENPashankar D, Shah S, Caprio S. PREVALENCE OF GASTROESOPHAGEAL REFLUX SYMPTOMS IN OBESE CHILDREN Journal Of Pediatric Gastroenterology And Nutrition 2006, 43: e18. DOI: 10.1097/00005176-200610000-00042.
  • 224 Increased Prevalence of Obesity in Children with Functional Constipation with and Without Fecal IncontinenceLoening-Baucke V, Pashankar D. 224 Increased Prevalence of Obesity in Children with Functional Constipation with and Without Fecal Incontinence Pediatric Research 2005, 58: 392-392. DOI: 10.1203/00006450-200508000-00253.
  • Pharmacotherapy of constipation in childrenPashankar D, Tolia V. Pharmacotherapy of constipation in children Journal Of Clinical Practice 2004, 1: 149-157. DOI: 10.2217/14750708.1.1.149.
  • P0474 POLYETHYLENE GLYCOL WITHOUT ELECTROLYTES FOR THE TREATMENT OF CONSTIPATION IN INFANTS AND TODDLERSLoening-Baucke V, Pashankar D, Krishna R, Comstock J. P0474 POLYETHYLENE GLYCOL WITHOUT ELECTROLYTES FOR THE TREATMENT OF CONSTIPATION IN INFANTS AND TODDLERS Journal Of Pediatric Gastroenterology And Nutrition 2004, 39: s236-s237. DOI: 10.1097/00005176-200406001-00598.
  • A randomized prospective comparison study of polyethylene glycol without electrolytes and milk of magnesia for children with constipation and encopresisLoening-Baucke V, Pashankar D. A randomized prospective comparison study of polyethylene glycol without electrolytes and milk of magnesia for children with constipation and encopresis Gastroenterology 2003, 124: a222. DOI: 10.1016/s0016-5085(03)81117-4.
  • Jaundice in Older Children and AdolescentsPashankar D, Schreiber R. Jaundice in Older Children and Adolescents Pediatrics In Review 2001, 22: 219-226. DOI: 10.1542/pir.22.7.219.
  • Efficacy and optimal dose of dally polyethylene glycol 3350 (PEG) for treat of chronic coastipation and encopresis in childrenBishop W, Pashankar D. Efficacy and optimal dose of dally polyethylene glycol 3350 (PEG) for treat of chronic coastipation and encopresis in children Gastroenterology 2001, 120: a754. DOI: 10.1016/s0016-5085(08)83759-6.
  • Omeprazole therapy for children with a failed fundoplicatlon: An alternative to repeat surgeryPashankar D, Blair G, Israel D. Omeprazole therapy for children with a failed fundoplicatlon: An alternative to repeat surgery Gastroenterology 2000, 118: a179. DOI: 10.1016/s0016-5085(00)82791-2.
  • EFFECT OF LONG TERM OMEPRAZOLE TREATMENT ON GASTRIC ANTRAL G AND D CELLSPashankar D, Israel D, Jevon G, Buchan A. EFFECT OF LONG TERM OMEPRAZOLE TREATMENT ON GASTRIC ANTRAL G AND D CELLS Journal Of Pediatric Gastroenterology And Nutrition 1999, 29: 505. DOI: 10.1097/00005176-199910000-00089.
  • ENDOSCOPIC GASTRIC CHANGES IN CHILDREN ON LONG-TERM OMEPRAZOLE THERAPYPashankar D, Israel D. ENDOSCOPIC GASTRIC CHANGES IN CHILDREN ON LONG-TERM OMEPRAZOLE THERAPY Journal Of Pediatric Gastroenterology And Nutrition 1998, 27: 479. DOI: 10.1097/00005176-199810000-00086.
  • Perianal Crohn's Disease in InfancyPashankar D, Schreiber R, Israel D. Perianal Crohn's Disease in Infancy Journal Of Pediatric Gastroenterology And Nutrition 1998, 27: 487. DOI: 10.1097/00005176-199810000-00118.
  • VITILIGO AND CROHN'S DISEASE IN CHILDRENPashankar D, Prendiville J, Israel D. VITILIGO AND CROHN'S DISEASE IN CHILDREN Journal Of Pediatric Gastroenterology And Nutrition 1997, 25: 450. DOI: 10.1097/00005176-199710000-00048.